CDH3 and neoplasm: We evaluated the tumor-suppressive effects of 90Y-FF-21101, FF-21101, and 90Y-labeled P-cadherin nonspecific antibody in a mouse xenograft model and estimated the clinical safety of 90Y-FF-21101 in humans by evaluating biodistribution in nonhuman primates and then extrapolating those results to patients.